Skip to main content
OpenTrials

Clinical trial condition

AML/MDS

Explore clinical trials studying AML/MDS. Study availability and eligibility vary by location and protocol.

6 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

AML/MDS trial results

Completed

Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML

NCT04139434

Conditions
AML/MDS, CMML, Disease Attributes, +20 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • University of Cincinnati Cincinnati, Ohio, United States
  • Ohio State Comprehensive Cancer Center Columbus, Ohio, United States
  • MD Anderson Cancer Center Huston, Texas, United States
View Trial Details
Active, Not Recruiting

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

NCT06325748

Conditions
AML/MDS, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, +33 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • TriStar Bone Marrow Transplant Nashville, Tennessee, United States
View Trial Details

Related conditions